Get the Stockscreener App
5.37
1.83%
-0.10
After Hours:
5.38
0.010
+0.19%
Optinose Inc stock is traded at $5.37, with a volume of 12,945.
It is down -1.83% in the last 24 hours and down -4.45% over the past month.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
See More
Previous Close:
$5.47
Open:
$5.5
24h Volume:
12,945
Relative Volume:
0.35
Market Cap:
$54.00M
Revenue:
$75.67M
Net Income/Loss:
$-31.15M
P/E Ratio:
-19.34
EPS:
-0.2777
Net Cash Flow:
$-39.79M
1W Performance:
+1.13%
1M Performance:
-4.45%
6M Performance:
-60.44%
1Y Performance:
-81.45%
1-Day Range:
$5.36
$5.53
1-Week Range:
$5.11
$5.61
52-Week Range:
$4.815
$31.50
Optinose Inc Stock (OPTN) Company Profile
Name
Optinose Inc
Sector
Phone
267-364-3500
Address
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Compare OPTN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
5.37 | 54.00M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
160.06 | 71.67B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.44B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 46.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.36 | 13.97B | 612.78M | -86.37M | -62.91M | -0.87 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-11-24 | Initiated | H.C. Wainwright | Buy |
| Aug-21-23 | Initiated | Lake Street | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-19 | Initiated | Cowen | Outperform |
| Aug-08-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Optinose Inc Stock (OPTN) Latest News
Optinose to Announce Q4 and Full-Year 2024 Financial Results on March 20, 2025 - MyChesCo
OptiNose (NASDAQ:OPTN) shareholders have endured a 90% loss from investing in the stock five years ago - Yahoo Finance
OptiNose (OPTN) Projected to Post Quarterly Earnings on Thursday - Defense World
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Optinose to Announce Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025 - Nasdaq
Optinose to Reveal Full Year Performance: Key Financial Results Coming March 20 - StockTitan
OptiNose, Inc. to Host Earnings Call - ACCESS Newswire
How the (OPTN) price action is used to our Advantage - Stock Traders Daily
Optinose CEO Mahmoud Ramy sells $33,729 in common stock By Investing.com - Investing.com South Africa
Optinose chief commercial officer sells $6,469 in stock - Investing.com India
Optinose chief commercial officer sells $6,469 in stock By Investing.com - Investing.com South Africa
Optinose CEO Mahmoud Ramy sells $33,729 in common stock - Investing.com
OptiNose Executives Sell Shares to Cover Tax Obligations - TradingView
Long Term Trading Analysis for (OPTN) - Stock Traders Daily
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Growth in Short Interest - MarketBeat
(OPTN) Technical Pivots with Risk Controls - Stock Traders Daily
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Decline in Short Interest - MarketBeat
Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE - MSN
OptiNose (STU:0OP0) Inventories, Raw Materials & Components : €2.05 Mil (As of Sep. 2024) - GuruFocus.com
OptiNose (FRA:0OP0) Earnings per Share (Diluted) : €-3.84 (TTM As of Sep. 2024) - GuruFocus.com
Lake Street Capital Issues Pessimistic Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
OptiNose (NASDAQ:OPTN) Price Target Cut to $17.00 by Analysts at Lake Street Capital - MarketBeat
OptiNose (FRA:0OP0) Short-Term Capital Lease Obligation : €0.91 Mil (As of Sep. 2024) - GuruFocus.com
Optinose price target adjusted for stock split at Lake Street - Yahoo Finance
Optinose reports preliminary Q4 2024 XHANCE revenue - MSN
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewswire
OPTNOptiNose, Inc. Latest Stock News & Market Updates - StockTitan
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Optinose Reports Strong Q4: XHANCE Revenue Hits $22.4M with 20% Prescription Growth - StockTitan
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - GlobeNewswire Inc.
OptiNose (STU:0OP0) Profitability Rank : 3 (As of Sep. 2024) - GuruFocus.com
OptiNose (STU:0OP0) Change In Inventory : €-3.06 Mil (TTM As of Sep. 2024) - GuruFocus.com
OptiNose, Inc. (NASDAQ:OPTN) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
OptiNose (FRA:0OP0) Cyclically Adjusted Price-to-FCF : (As of Jan. 06, 2025) - GuruFocus.com
HC Wainwright Comments on OptiNose FY2029 Earnings - MarketBeat
HC Wainwright Forecasts OptiNose FY2029 Earnings - Defense World
Optinose price target adjusted for stock split at H.C. Wainwright - MSN
HC Wainwright Issues Positive Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
Optinose stock price target raised at H.C. Wainwright given reverse split - Investing.com Canada
OptiNose (NASDAQ:OPTN) Shares Down 6.1%Time to Sell? - MarketBeat
OptiNose: Q1 Earnings Snapshot - Marketscreener.com
OptiNose, Inc. Announces Executive Appointments - Marketscreener.com
Optinose Announces Board Changes - Marketscreener.com
OptiNose stock hits 52-week high of $6.2 amid market fluctuations - Investing.com Nigeria
OptiNose stock hits 52-week high of $6.2 amid market fluctuations By Investing.com - Investing.com South Africa
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
OptiNose (NASDAQ:OPTN) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Optinose Inc Stock (OPTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):